Author:
Chen Xiaolong,Hu Chenmin,Yan Chenxi,Tao Enfu,Zhu Zhenya,Shu Xiaoli,Guo Rui,Jiang Mizu
Abstract
AbstractWe assessed dynamic changes in visceral hypersensitivity and fecal metabolomics through a mouse model of irritable bowel syndrome (IBS) from childhood to adulthood. A mouse model of IBS was constructed with maternal separation (MS) in early life. Male mice aged 25, 40, and 70 days were used. Visceral sensitivity was assessed by recording the reaction between the abdominal withdrawal reflex and colorectal distension. Metabolomics was identified and quantified by liquid chromatography-tandem mass spectrometry. The visceral sensitivity of the MS group was significantly higher than that of the non-separation (NS) group in the three age groups. The top four fecal differential metabolites in the different age groups were lipids, lipid molecules, organic heterocyclic compounds, organic acids and derivatives, and benzenoids. Five identical differential metabolites were detected in the feces and ileal contents of the MS and NS groups at different ages, namely, benzamide, taurine, acetyl-L-carnitine, indole, and ethylbenzene. Taurine and hypotaurine metabolism were the most relevant pathways at P25, whereas histidine metabolism was the most relevant pathway at P40 and P70. Visceral hypersensitivity in the MS group lasted from childhood to adulthood. The different metabolites and metabolic pathways detected in MS groups of different ages provide a theoretical basis for IBS pathogenesis.
Funder
a grant from the Key Research, Development Project of Zhejiang Province
a project from the National Clinical Research Center for Child Health
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Sperber, A. D. et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: A Rome Foundation working team literature review. Gut 66, 1075–1082 (2017).
2. Ohman, L. & Simrén, M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver 39, 201–215 (2007).
3. Noor, S. O. et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 10, 134 (2010).
4. Ringel-Kulka, T. et al. Altered colonic bacterial fermentation as a potential pathophysiological factor in irritable bowel syndrome. Off. J. Am. Coll. Gastroenterol.|ACG 110, 1339–1346 (2015).
5. Bradford, K. et al. Association between early adverse life events and irritable bowel syndrome. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 10, 385-390.e3 (2012).